Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$13.62+0.77 (+5.99%)
Close on Nov 18, 2026Market cap $182.28MP/E –Yield –
Anika Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Anika Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was $5.98M, down 4.8% year over year. For fiscal 2025 it was $11.19M, up 107.1% from the year before. Over ten years it grew -11.9% a year on average. The highest annual figure on record is $40.81M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.19M | +107.1% |
| FY2024 | Dec 31, 2024 | $5.40M | – |
| FY2023 | Dec 31, 2023 | -$1.79M | -140.6% |
| FY2022 | Dec 31, 2022 | $4.41M | -47.5% |
| FY2021 | Dec 31, 2021 | $8.40M | -35.7% |
| FY2020 | Dec 31, 2020 | $13.07M | -64.7% |
| FY2019 | Dec 31, 2019 | $37.01M | +6.0% |
| FY2018 | Dec 31, 2018 | $34.92M | -14.4% |
| FY2017 | Dec 31, 2017 | $40.81M | +66.9% |
| FY2016 | Dec 31, 2016 | $24.45M | -38.7% |
| FY2015 | Dec 31, 2015 | $39.91M | -0.2% |
| FY2014 | Dec 31, 2014 | $39.98M | +58.9% |
| FY2013 | Dec 31, 2013 | $25.17M | +138.6% |
| FY2012 | Dec 31, 2012 | $10.55M | +3.7% |
| FY2011 | Dec 31, 2011 | $10.17M | +29.5% |
| FY2010 | Dec 31, 2010 | $7.85M | +153.8% |
| FY2009 | Dec 31, 2009 | $3.09M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$684.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $4.64M | +193.1% |
| Q3 FY2025 | Sep 30, 2025 | $6.87M | +37.0% |
| Q2 FY2025 | Jun 30, 2025 | -$189.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$130.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $1.58M | -56.5% |
| Q3 FY2024 | Sep 30, 2024 | $5.02M | -22.7% |
| Q2 FY2024 | Jun 30, 2024 | -$1.07M | – |
| Q1 FY2024 | Mar 31, 2024 | -$126.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $3.64M | +656.3% |
| Q3 FY2023 | Sep 30, 2023 | $6.49M | +139.4% |
| Q2 FY2023 | Jun 30, 2023 | -$8.29M | -368.6% |
| Q1 FY2023 | Mar 31, 2023 | -$3.62M | – |
| Q4 FY2022 | Dec 31, 2022 | $481.00K | -89.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.71M | +31.4% |
| Q2 FY2022 | Jun 30, 2022 | $3.09M | -28.1% |
| Q1 FY2022 | Mar 31, 2022 | -$1.87M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.47M | +72.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.06M | -64.8% |
| Q2 FY2021 | Jun 30, 2021 | $4.29M | +20.3% |
| Q1 FY2021 | Mar 31, 2021 | -$2.43M | -332.6% |
| Q4 FY2020 | Dec 31, 2020 | $2.59M | -80.1% |
| Q3 FY2020 | Sep 30, 2020 | $5.87M | -41.6% |
| Q2 FY2020 | Jun 30, 2020 | $3.57M | -34.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.05M | -87.7% |
| Q4 FY2019 | Dec 31, 2019 | $13.02M | +30.1% |
| Q3 FY2019 | Sep 30, 2019 | $10.05M | -7.3% |
| Q2 FY2019 | Jun 30, 2019 | $5.47M | +22.3% |
| Q1 FY2019 | Mar 31, 2019 | $8.46M | -11.8% |
| Q4 FY2018 | Dec 31, 2018 | $10.01M | +43.4% |
| Q3 FY2018 | Sep 30, 2018 | $10.84M | -10.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.47M | -28.7% |
| Q1 FY2018 | Mar 31, 2018 | $9.59M | -38.0% |
| Q4 FY2017 | Dec 31, 2017 | $6.98M | +15.0% |
| Q3 FY2017 | Sep 30, 2017 | $12.10M | +6.9% |
| Q2 FY2017 | Jun 30, 2017 | $6.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.46M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.07M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.32M | – |
See a number that looks wrong?